-
Je něco špatně v tomto záznamu ?
The impact of p53 on DNA damage and metabolic activation of the environmental carcinogen benzo[a]pyrene: effects in Trp53(+/+), Trp53(+/-) and Trp53(-/-) mice
AM. Krais, EN. Speksnijder, JP. Melis, R. Indra, M. Moserova, RW. Godschalk, FJ. van Schooten, A. Seidel, K. Kopka, HH. Schmeiser, M. Stiborova, DH. Phillips, M. Luijten, VM. Arlt,
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články, práce podpořená grantem
Medline Complete (EBSCOhost) od 2000-01-01 do Před 1 rokem
Health & Medicine (ProQuest) od 2002-01-01 do Před 1 rokem
Public Health Database (ProQuest) od 2002-01-01 do Před 1 rokem
Odkazy
PubMed
25995008
DOI
10.1007/s00204-015-1531-8
Knihovny.cz E-zdroje
- MeSH
- adukty DNA metabolismus MeSH
- benzopyren metabolismus farmakokinetika MeSH
- cytochrom P-450 CYP1A1 metabolismus MeSH
- jaterní mikrozomy účinky léků metabolismus MeSH
- karcinogeny životního prostředí metabolismus farmakokinetika MeSH
- ledviny účinky léků metabolismus MeSH
- metabolická aktivace MeSH
- metabolická inaktivace MeSH
- mutantní kmeny myší MeSH
- myši inbrední C57BL MeSH
- NAD(P)H dehydrogenasa (chinon) metabolismus MeSH
- nádorový supresorový protein p53 genetika metabolismus MeSH
- poškození DNA účinky léků genetika MeSH
- zvířata MeSH
- Check Tag
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The tumour suppressor p53 is one of the most important cancer genes. Previous findings have shown that p53 expression can influence DNA adduct formation of the environmental carcinogen benzo[a]pyrene (BaP) in human cells, indicating a role for p53 in the cytochrome P450 (CYP) 1A1-mediated biotransformation of BaP in vitro. We investigated the potential role of p53 in xenobiotic metabolism in vivo by treating Trp53(+/+), Trp53(+/-) and Trp53(-/-) mice with BaP. BaP-DNA adduct levels, as measured by (32)P-postlabelling analysis, were significantly higher in liver and kidney of Trp53(-/-) mice than of Trp53(+/+) mice. Complementarily, significantly higher amounts of BaP metabolites were also formed ex vivo in hepatic microsomes from BaP-pretreated Trp53(-/-) mice. Bypass of the need for metabolic activation by treating mice with BaP-7,8-dihydrodiol-9,10-epoxide resulted in similar adduct levels in liver and kidney in all mouse lines, confirming that the influence of p53 is on the biotransformation of the parent compound. Higher BaP-DNA adduct levels in the livers of Trp53(-/-) mice correlated with higher CYP1A protein levels and increased CYP1A enzyme activity in these animals. Our study demonstrates a role for p53 in the metabolism of BaP in vivo, confirming previous in vitro results on a novel role for p53 in CYP1A1-mediated BaP metabolism. However, our results also suggest that the mechanisms involved in the altered expression and activity of the CYP1A1 enzyme by p53 in vitro and in vivo are different.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17001136
- 003
- CZ-PrNML
- 005
- 20171215201520.0
- 007
- ta
- 008
- 170103s2016 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00204-015-1531-8 $2 doi
- 024 7_
- $a 10.1007/s00204-015-1531-8 $2 doi
- 035 __
- $a (PubMed)25995008
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Krais, Annette M $u Analytical and Environmental Sciences Division, MRC-PHE Centre for Environment & Health, King's College London, Franklin-Wilkins Building, 150 Stamford Street, London, SE1 9NH, UK.
- 245 14
- $a The impact of p53 on DNA damage and metabolic activation of the environmental carcinogen benzo[a]pyrene: effects in Trp53(+/+), Trp53(+/-) and Trp53(-/-) mice / $c AM. Krais, EN. Speksnijder, JP. Melis, R. Indra, M. Moserova, RW. Godschalk, FJ. van Schooten, A. Seidel, K. Kopka, HH. Schmeiser, M. Stiborova, DH. Phillips, M. Luijten, VM. Arlt,
- 520 9_
- $a The tumour suppressor p53 is one of the most important cancer genes. Previous findings have shown that p53 expression can influence DNA adduct formation of the environmental carcinogen benzo[a]pyrene (BaP) in human cells, indicating a role for p53 in the cytochrome P450 (CYP) 1A1-mediated biotransformation of BaP in vitro. We investigated the potential role of p53 in xenobiotic metabolism in vivo by treating Trp53(+/+), Trp53(+/-) and Trp53(-/-) mice with BaP. BaP-DNA adduct levels, as measured by (32)P-postlabelling analysis, were significantly higher in liver and kidney of Trp53(-/-) mice than of Trp53(+/+) mice. Complementarily, significantly higher amounts of BaP metabolites were also formed ex vivo in hepatic microsomes from BaP-pretreated Trp53(-/-) mice. Bypass of the need for metabolic activation by treating mice with BaP-7,8-dihydrodiol-9,10-epoxide resulted in similar adduct levels in liver and kidney in all mouse lines, confirming that the influence of p53 is on the biotransformation of the parent compound. Higher BaP-DNA adduct levels in the livers of Trp53(-/-) mice correlated with higher CYP1A protein levels and increased CYP1A enzyme activity in these animals. Our study demonstrates a role for p53 in the metabolism of BaP in vivo, confirming previous in vitro results on a novel role for p53 in CYP1A1-mediated BaP metabolism. However, our results also suggest that the mechanisms involved in the altered expression and activity of the CYP1A1 enzyme by p53 in vitro and in vivo are different.
- 650 _2
- $a metabolická aktivace $7 D065767
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a benzopyren $x metabolismus $x farmakokinetika $7 D001564
- 650 _2
- $a karcinogeny životního prostředí $x metabolismus $x farmakokinetika $7 D002274
- 650 _2
- $a cytochrom P-450 CYP1A1 $x metabolismus $7 D019363
- 650 _2
- $a adukty DNA $x metabolismus $7 D018736
- 650 _2
- $a poškození DNA $x účinky léků $x genetika $7 D004249
- 650 _2
- $a metabolická inaktivace $7 D008658
- 650 _2
- $a ledviny $x účinky léků $x metabolismus $7 D007668
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a myši inbrední C57BL $7 D008810
- 650 _2
- $a mutantní kmeny myší $7 D008817
- 650 _2
- $a jaterní mikrozomy $x účinky léků $x metabolismus $7 D008862
- 650 _2
- $a NAD(P)H dehydrogenasa (chinon) $x metabolismus $7 D016660
- 650 _2
- $a nádorový supresorový protein p53 $x genetika $x metabolismus $7 D016159
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Speksnijder, Ewoud N $u Center for Health Protection, National Institute for Public Health and the Environment (RIVM), 3721 MA, Bilthoven, The Netherlands. Department of Human Genetics, Leiden University Medical Center, 2300 RC, Leiden, The Netherlands.
- 700 1_
- $a Melis, Joost P M $u Center for Health Protection, National Institute for Public Health and the Environment (RIVM), 3721 MA, Bilthoven, The Netherlands. Department of Human Genetics, Leiden University Medical Center, 2300 RC, Leiden, The Netherlands.
- 700 1_
- $a Indra, Radek $u Department of Biochemistry, Faculty of Science, Charles University, 12840, Prague 2, Czech Republic.
- 700 1_
- $a Moserova, Michaela $u Department of Biochemistry, Faculty of Science, Charles University, 12840, Prague 2, Czech Republic.
- 700 1_
- $a Godschalk, Roger W $u Department of Toxicology, School for Nutrition, Toxicology and Metabolism (NUTRIM), Maastricht University Medical Centre, 6200 MD, Maastricht, The Netherlands.
- 700 1_
- $a van Schooten, Frederik-J $u Department of Toxicology, School for Nutrition, Toxicology and Metabolism (NUTRIM), Maastricht University Medical Centre, 6200 MD, Maastricht, The Netherlands.
- 700 1_
- $a Seidel, Albrecht $u Biochemical Institute for Environmental Carcinogens, Prof. Dr. Gernot Grimmer-Foundation, 22927, Grosshansdorf, Germany.
- 700 1_
- $a Kopka, Klaus $u Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
- 700 1_
- $a Schmeiser, Heinz H $u Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
- 700 1_
- $a Stiborova, Marie $u Department of Biochemistry, Faculty of Science, Charles University, 12840, Prague 2, Czech Republic.
- 700 1_
- $a Phillips, David H $u Analytical and Environmental Sciences Division, MRC-PHE Centre for Environment & Health, King's College London, Franklin-Wilkins Building, 150 Stamford Street, London, SE1 9NH, UK.
- 700 1_
- $a Luijten, Mirjam $u Center for Health Protection, National Institute for Public Health and the Environment (RIVM), 3721 MA, Bilthoven, The Netherlands. Department of Human Genetics, Leiden University Medical Center, 2300 RC, Leiden, The Netherlands.
- 700 1_
- $a Arlt, Volker M. $u Analytical and Environmental Sciences Division, MRC-PHE Centre for Environment & Health, King's College London, Franklin-Wilkins Building, 150 Stamford Street, London, SE1 9NH, UK. volker.arlt@kcl.ac.uk. $7 xx0074763 $4
- 773 0_
- $w MED00009265 $t Archives of toxicology $x 1432-0738 $g Roč. 90, č. 4 (2016), s. 839-51
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25995008 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170103 $b ABA008
- 991 __
- $a 20170112121429 $b ABA008
- 999 __
- $a ok $b bmc $g 1180276 $s 961703
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 90 $c 4 $d 839-51 $e 20150521 $i 1432-0738 $m Archives of toxicology $n Arch Toxicol $x MED00009265
- LZP __
- $a Pubmed-20170103